Weekly Stocks Market Recap. Feb 26- March 2, 2018


04-Mar-2018 14:20 PM



     The New Home Sales number released on Monday were 593k vs 655k estimate. For January, New Home sales -7.8% vs 3.2% . Dow Jones finished+399.28 points, SPY +1.16%, QQQ +1.33%, IBB +0.73%.

     On Tuesday, Fed chair Jerome Powell testifies sees gradual rate hikes amid strong U.S. growth outlook.  Economic data are: Durable Goods Orders (MoM) -3.7% vs -2.4%, Goods Trade Balance -74.40B vs -72.30B, Fed Powell hints of possible 4 rate hikes this year, market pullback after his comment. Dow Jones close -299.24 points, SPY -1.25%, QQQ -1.24%, IBB -1.25%

     Wednesday economic data: Pending Homes Sales (MoM) for January 0.4% vs 0.5% est, GDP for Q4 2.5% vs 2.5% estimate.  GDP Price Index 2.3% vs 2.4% estimate. Pending home sales drop 4.7 % vs 0.4% consensus. Dow Jones closes -381.6 points, SPY -1.10%, IWM -1.53%, IBB -1.83% and QQQ -1.08%, this snap the longest winning streak since 1959. The S&p 500 close the month -3.65%.

     The economy data on Thursday are: Initial Jobless Claims 210k vs 226k est, Personal Income 0.4% vs 0.3%, Continuing Jobless Claims 1.93k vs 1.93k estimate. Powell's testimony no evidence that economy currently overheating.  President Trump added Tariff to all import steels, market react badly with Dow Jones close-424.56 points, SPY --1.45%, IWM -0.31%, QQQ -1.63% and IBB-0.96%. This is the third straight days this week with major indexes closed -1%.

     The market follow through on Friday with Dow Jones -330 points  at the opening bell, SPY -2.02% intraday. Notable during the day small cap biotech leading the rallies, some names are:

  • Puma Biotechnology (PBYI:NASDAQ)
  • Nektar Therapeutics (NKTR:NASDAQ)
  • ChemoCentryx Inc (CCXI:NASDAQ)
  • Intra-Cellular Therapies Inc (ITCI:NASDAQ)
  • Protagonist Therapeutics Inc (PGTX:NASDAQ)
  • Fate Therapeutics Inc (FATE:NASDAQ)

Dow Jones made a recovery from -300+ down day to end -70.92 points, SPY +0.52%, IWM +1.60%, QQQ +0.92% and IBB +2.44%,

These stocks ticker are the notable movers with news this week.


  • MDXG investigating MiMedx sales, distribution via Bloomberg
  • OBSV press release of positive data
  • AAPL relative strength due to Warren Buffett added stake in company, they now hold 165.3 million share




  • CRM earning report
  • DDD preliminary earning release see Q4 NON-gaap eps 3c-5c VS 1c
  • PTLA yesterday's after hours, company stated that FDA indicated it may request a randomized study for AndexXA
  • AGN stock took impact from news that MYL and RVNC collaboration for Botox biosimilar.


  • JCP J.C Penney cuts hundreds of jobs and close seven stores in 2018
  • ZSAN issuance of U.S. patent covering M207. (Low float stock)
  • NKTR announced positive update on NKTR-214

Thanks for reading our recap.

Contact us:

Twitter: @BiotechMoney18




Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.